OM DENNE EPISODE

Engelsk
USA

UDSKRIFT 🔗

SØK BLANT TIDLIGERE EPISODER

Søk etter gamle episoder av Proactive - Interviews for investors.

ANDRE EPISODE I DENNE PODKAST

Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) President and Chief Technology Officer Nicolas Loebel spoke with Proactive's Stephen Gunnion about the company’s £10 million fundraising, positive top-line Phase 3 results and plans to bring its nasal photodisinfection technology to the US market. Loebel …
Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) CEO Matt Wood and CFO Amit Gupta spoke with Proactive's Stephen Gunnion after the battery technology company delivered FY2026 results ahead of market expectations and advanced plans to commercialise its nano-encapsulated sulfur (NES) technology. Gupta repo…
Renforth Resources Inc (CSE:RFR, OTCQB:RFHRF) CEO Nicole Brewster spoke with Proactive's Stephen Gunnion about new gold intersections at its Parbec deposit in Quebec, the planned resource review and next steps towards assessing development options. Two drillholes beneath recent surface discoveries…
Immunic Inc (NASDAQ:IMUX, FRA:10VA) CEO Erik Lundgren joined Proactive's Stephen Gunnion to discuss four posters the company will present at MSToronto2026, the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto from October 21–23. The presentations explore the potential of vidofludimus calcium, Immunic…
Recce Pharmaceuticals Ltd chief executive James Graham talked with Proactive about the company’s Phase 3 trial of RECCE® 327 Gel, or R327G, for the treatment of diabetic foot infections in Indonesia and the upcoming review of trial data by an independent Data Monitoring Committee. Graham said the …
Ansvarsfraskrivelse: Podkasten og kunstværket, det finnes indlejret på denne siden, er fra Proactive, som tilhører dens eier og ikke er tilknyttet eller godkjent av Listen Notes, Inc.